Skip to main content

Profile

jkt5560

Limiting non-indicated proton pump inhibitor use in patients with cirrhosis

Background Proton pump inhibitors (PPI) are among the most common medications used in the US. Many patients (estimated at 63% in some studies) do not have a clear indication for PPI use. Recent literature supports association between PPI use and infection, hepatic decompensation, and liver-related mortality in patients with cirrhosis. Figure 1.  Relative hazard of

Do all admitted patients require venous thromboembolism prophylaxis?

In the process of every admission , Epic requires the admitting provider to select the method of venous thromboembolism (VTE) prophylaxis or a contraindication before the orders can be signed. Further, VTE prophylaxis is on many of our admission checklists as topics that must be addressed prior to completing the admission. However, in these low-risk